| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 46691 | Null | 0.0462077035966084 | -0.21941347 |
| NSC 603086 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- | 0.0462077035966084 | 0.63057179 |
| NSC 603555 | 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride | 0.0462077035966084 | 0.57393091 |
| NSC 607993 | Null | 0.0462077035966084 | -0.30318645 |
| NSC 617823 | 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride | 0.0462077035966084 | 0.51513153 |
| NSC 619102 | 4-Methoxy-1,5-benzothiazepine-1,1-dioxide | 0.0462077035966084 | 0.55471942 |
| NSC 634785 | 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride | 0.0462077035966084 | 0.58839922 |
| NSC 639981 | Null | 0.0462077035966084 | 0.62664904 |
| NSC 642049 | Acetamide, N-(3-acetylphenyl)-2-[(4-amino-5-mercapto- 4H-1,2,4-triazol-3-yl)hydrazino]-2-oxo- | 0.0462077035966084 | 0.12761158 |
| NSC 645317 | Sanguilutine pseudobase | 0.0462077035966084 | 0.48982234 |